Año 2021 / Volumen 113 / Número 6
Original
Management of small intestinal bacterial overgrowth by pediatric gastroenterologists in Spain

436-441

DOI: 10.17235/reed.2020.7582/2020

Rafael Martín-Masot, Manuel Molina Arias, Juan José Díaz Martín, María Luz Cilleruelo Pascual, Carolina Gutiérrez Junquera, Ester Donat, Enriqueta Román Riechmann, Víctor M. Navas-López,

Resumen
Background: small intestinal bacterial overgrowth (SIBO) is a heterogeneous condition with nonspecific symptoms. This study aimed to report its management by pediatric gastroenterologists in Spain. Methods: a descriptive study was performed by means of a survey sent to 184 active members of the Spanish Society of Pediatric Gastroenterology, Hepatology and Nutrition (SEGHNP). Results: one hundred and forty-eight responses (80.4 %) were received. Forty-four patients had no predisposing condition, 31.1 % used antibiotics followed by probiotics, 33.1 % antibiotherapy concomitant with probiotics, 24.3 % only antibiotics and 10.8 % only probiotics. The diagnosis was established via clinical parameters in 73.8 % of participants and the therapeutic response was checked only by clinical data in 90 %. Conclusions: there is high variability in the management of SIBO among pediatric population in Spain.
Share Button
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Bibliografía
1. Shimura S, Ishimura N, Mikami H, et al. Small intestinal bacterial overgrowth in patients with refractory functional gastrointestinal disorders. J. Neurogastroenterol. Motil. 2016;22:60–8. doi:10.5056/jnm15116.
2. Cares K, Al-Ansari N, MacHa S, et al. Short article: Risk of small intestinal bacterial overgrowth with chronic use of proton pump inhibitors in children. Eur. J. Gastroenterol. Hepatol. 2017;29:396–9.doi:10.1097/MEG.0000000000000815.
3. Siddiqui I, Ahmed S, Abid S. Update on diagnostic value of breath test in gastrointestinal and liver diseases. World J. Gastrointest. Pathophysiol. 2016;7:256. doi:10.4291/wjgp.v7.i3.256.
4. Sieczkowska A, Landowski P, Kaminska B, et al. Small Bowel Bacterial Overgrowth in Children. J. Pediatr. Gastroenterol. Nutr. 2016;62:196–207. doi:10.1097/MPG.0000000000000920.
5. Román E, Cilleruelo M. Síndrome de sobredesarrollo bacteriano. In: Ergon, editor. Tratamiento en Gastroenterología, Hepatología y Nutrición Pediátrica. 2016. page 343–53.
6. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 2009;42:377–81. doi:10.1016/j.jbi.2008.08.010.
7. Shimura S, Ishimura N, Mikami H, et al. Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders. J. Neurogastroenterol. Motil. 2015;22:60–8. doi:10.5056/jnm15116.
8. Rezaie A, Buresi M, Lembo A, et al. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am. J. Gastroenterol. 2017;112:775–84. doi:10.1038/ajg.2017.46.
9. Tahan S, Melli LCFL, Mello CS, et al. Effectiveness of trimethoprim-sulfamethoxazole and metronidazole in the treatment of small intestinal bacterial overgrowth in children living in a slum. J. Pediatr. Gastroenterol. Nutr. 2013;57:316–8. doi:10.1097/MPG.0b013e3182952e93.
10. Scarpellini E, Giorgio V, Gabrielli M, et al. Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome: A preliminary study. Eur. Rev. Med. Pharmacol. Sci. 2013;17:1314–20. doi:10.1016/s0016-5085(11)63101-6.
11. Collins BS, Lin HC. Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain. J. Pediatr. Gastroenterol. Nutr. 2011;52:382–6. doi:10.1097/MPG.0b013e3181effa3b.
12. Shah SC, Day LW, Somsouk M, et al. Meta-analysis: Antibiotic therapy for small intestinal bacterial overgrowth. Aliment. Pharmacol. Ther. 2013;38:925–34. doi:10.1111/apt.12479.
13. Gatta L, Scarpignato C, McCallum RW, et al. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment. Pharmacol. Ther.2017;45:604–16. doi: 10.1111/apt.13928
14. Zhong C, Qu C, Wang B, et al. Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth. J. Clin. Gastroenterol.2017;51:300–11. doi: 10.1097/MCG.0000000000000814.
15. Dionne J, Ford AC, Yuan Y, et al. A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome. Am. J. Gastroenterol.2018;113:1290–300. doi: 10.1038/s41395-018-0195-4.
Artículos relacionados

Carta

Pneumatosis intestinalis in a pediatric patient

DOI: 10.17235/reed.2021.8482/2021

Caso Clínico

Enfermedad de Crohn metastásica en pediatría

DOI: 10.17235/reed.2016.3948/2015

Instrucciones para citar
Martín-Masot R, Molina Arias M, Díaz Martín J, Cilleruelo Pascual M, Gutiérrez Junquera C, Donat E, et all. Management of small intestinal bacterial overgrowth by pediatric gastroenterologists in Spain. 7582/2020


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 987 veces.
Este artículo ha sido descargado 431 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 10/10/2020

Aceptado: 31/10/2020

Prepublicado: 29/12/2020

Publicado: 04/06/2021

Tiempo de revisión del artículo: 11 días

Tiempo de prepublicación: 80 días

Tiempo de edición del artículo: 237 días


Compartir
Este artículo aun no tiene valoraciones.
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas